Renin-angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID...
Renin-angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials
About this item
Full title
Renin-angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials
Author / Creator
Publisher
England: Nature Publishing Group
Journal title
Hypertension research, 2021-08, Vol.44 (8), p.1042-1045
Language
English
Formats
Publication information
Publisher
England: Nature Publishing Group
Subjects
More information
Alternative Titles
Full title
Renin-angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8134827
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8134827
Other Identifiers
ISSN
0916-9636
E-ISSN
1348-4214
DOI
10.1038/s41440-021-00670-w
